Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Short-Term Debt issuances (2016 - 2025)

Historic Short-Term Debt issuances for Xtant Medical Holdings (XTNT) over the last 8 years, with Q3 2025 value amounting to $25.8 million.

  • Xtant Medical Holdings' Short-Term Debt issuances fell 369.72% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.9 million, marking a year-over-year decrease of 484.57%. This contributed to the annual value of $112.6 million for FY2024, which is 4400.59% up from last year.
  • Xtant Medical Holdings' Short-Term Debt issuances amounted to $25.8 million in Q3 2025, which was down 369.72% from $26.7 million recorded in Q2 2025.
  • Xtant Medical Holdings' Short-Term Debt issuances' 5-year high stood at $30.4 million during Q1 2024, with a 5-year trough of $10.1 million in Q3 2022.
  • In the last 5 years, Xtant Medical Holdings' Short-Term Debt issuances had a median value of $19.8 million in 2023 and averaged $20.6 million.
  • Its Short-Term Debt issuances has fluctuated over the past 5 years, first tumbled by 2473.21% in 2022, then soared by 8875.7% in 2023.
  • Over the past 5 years, Xtant Medical Holdings' Short-Term Debt issuances (Quarter) stood at $13.6 million in 2021, then increased by 29.09% to $17.5 million in 2022, then surged by 30.34% to $22.9 million in 2023, then grew by 15.09% to $26.3 million in 2024, then dropped by 2.14% to $25.8 million in 2025.
  • Its last three reported values are $25.8 million in Q3 2025, $26.7 million for Q2 2025, and $25.2 million during Q1 2025.